KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Sales (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Return on Sales readings, the most recent being 0.02% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02%, a 1.0% increase, with the full-year FY2025 number at 0.02%, up 1.0% from a year prior.
  • Return on Sales hit 0.02% in Q4 2025 for Ginkgo Bioworks Holdings, down from 0.02% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2024 to a low of 0.11% in Q4 2021.
  • Median Return on Sales over the past 5 years was 0.02% (2025), compared with a mean of 0.04%.
  • Biggest five-year swings in Return on Sales: dropped -9bps in 2021 and later rose 9bps in 2022.
  • Ginkgo Bioworks Holdings' Return on Sales stood at 0.11% in 2021, then soared by 84bps to 0.02% in 2022, then crashed by -246bps to 0.06% in 2023, then surged by 60bps to 0.02% in 2024, then rose by 1bps to 0.02% in 2025.
  • The last three reported values for Return on Sales were 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.